Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why BioNTech Stock Jumped Today

TheMotleyFool

0 0

Shares of BioNTech (NASDAQ: BNTX) closed Monday's trading session 8.6% higher, lifted largely by two developments.

First, on Monday, BioNTech announced a collaboration with Crescendo Biologics to develop immunotherapies for treating cancer and other diseases. And second, Pfizer (NYSE: PFE) CEO Albert Bourla said in an interview on CNBC that a new version of its COVID-19 vaccine that is designed to target the omicron variant would be ready by March. Pfizer and BioNTech are again working together to develop the omicron-specific vaccine.

Image source: Getty Images.

Source Fool.com

Like: 0

BNTX

Share